前列腺癌的精准医学:国际视角
Anis A Hamid1, Christopher J Sweeney2, Christopher Hovens3
1Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Surgery, University of Melbourne, Melbourne, Australia.
Urologic oncology
|April 13, 2024
概括
个性化医疗推进了前列腺癌治疗. 基因组分析揭示了新的治疗目标和组合策略,以改善患者护理和治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 精准医学是一门精准的医学.
背景情况:
- 前列腺癌的治疗已经从雄激素剥夺疗法显著进步.
- 综合性基因组分析已经确定了前列腺癌中可向的分子变异.
- 这种分子理解有助于开发新型和组合疗法.
研究的目的:
- 审查前列腺癌的分子生物学.
- 讨论用于预后和预测治疗效益的工具.
- 检查晚期前列腺癌的现代治疗方法作为精确信息的方法.
主要方法:
- 关于前列腺癌分子生物学的文献综述.
- 对基因组分析数据进行分析,以确定目标.
- 综合目前关于晚期前列腺癌治疗的证据.
主要成果:
- 前列腺癌基因组景观提供了许多治疗点.
- 预后和预测工具对于指导治疗选择至关重要.
- 精准医学越来越成为高级前列腺癌管理的核心.
结论:
- 个性化方法正在彻底改变前列腺癌治疗开发和患者选择.
- 了解分子驱动因素是优化治疗策略的关键.
- 对科学进步和护理的全球考虑对于精确瘤学至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K